https://www.marketscreener.com/quote/stock/MENDUS-AB-17946401/news/Mendus-announces-ethics-committee-approval-for-the-AMLM22-CADENCE-trial-with-lead-product-vididencel-46295032/?utm_source=telegram&utm_medium=social&utm_campaign=share